SYSaeed Yazdankhah

Saeed Yazdankhah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saeed Yazdankhah has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Ahmadreza Assareh

    Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    3 shared publications
  • Shahla Majidi

    Department of Cardiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    3 shared publications
  • Nasim Nasehi

    Department of Cardiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    2 shared publications
  • Abdalrahim Masjedizade

    Research Center for Infectious Diseases of Digestive System, Alimentary Tract Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    1 shared publication
  • Ahmad Ahmadzadeh

    Health Research Institute, Thalassemia and Hemoglobinopathies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    1 shared publication
  • Ali Kardooni

    Atherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    1 shared publication

Latest Publications

  • Open Access

    The Role of Short-term Low-Dose Atorvastatin in Improving Endothelial Function in Normolipidemic Heart Failure with Preserved Ejection Fraction

    by Seyed Mohammad Hassan Adel, Saeed Yazdankhah, Shahla Madjidi, Ali Kardooni, Saied Hesam

    Background: Heart failure with preserved ejection fraction (HFpEF) imposes a heavy burden on Iran’s health system. Although therapeutics are prescribed for HFpEF, no evidence-based therapy has been generally accepted. Endothelial dysfunction is currently recognized as a promising therapeutic target for patients with HFpEF. Methods: A total of 40 patients who referred to the echocardiography clinic of Imam Khomeini hospital in Ahvaz participated in this randomized clinical trial. Echocardiographic and clinical criteria for HFpEF and normal coronary angiography were recorded in all subjects. The patients did not have indications of statin therapy or a prior history of statin consumption. They were randomly assigned to the atorvastatin (20 mg once daily) and placebo groups (n=20 per group). Flow-mediated dilatation (FMD) of the brachial artery was measured in the two groups before the trial and after the two-month treatment period. Clinical trial registration is available from: https://irct.behdasht.gov.ir/, (identifier: IRCT2015010320538N1). Results: The patients’ mean age was 65 years, 40% were male, and 60% were female. There was a significant improvement in FMD only in the atorvastatin group (+41.5% in males and+18.25% in females) (P<0.001). The low-density lipoprotein (LDL) level significantly decreased after treatment in the atorvastatin group but not in the placebo group. The variation in FMD was not dramatically associated with the reduction in serum LDL in the two groups. Conclusion: Atorvastatin has advantageous effects on the vascular endothelial function of HFpEF, and this effect is not associated with its lipid-lowering properties.

  • Open Access

    Circulating HOTAIR LncRNA Is Potentially Up-regulated in Coronary Artery Disease

    by Niloofar Avazpour, Mohammadreza Hajjari, Saeed Yazdankhah, Azita Sahni, Ali Mohammad Foroughmand

    Coronary artery disease (CAD) is one of the leading causes of death and disability all around the world. Recent studies have revealed that aberrantly regulated long non-coding RNA (lncRNA) as one of the main classes of cellular transcript play a key regulatory role in transcriptional and epigenetic pathways. Recent reports have demonstrated circulating long noncoding RNAs in blood can be potential biomarkers for CAD. HOTAIR is one of the most cited lncRNAs with a critical role in initiation and progression of the gene expression regulation. Recent research on the role of the HOTAIR in cardiovascular disease lays the basis for the development of new studies considering this lncRNA as a potential biomarker and therapeutic target in CAD. In this study, we aimed to compare the expression of HOTAIR lncRNA in the blood samples of patients with CAD and control samples. The expression level was examined by semi-quantitative reverse transcriptase polymerase chain reaction technique. Our data show that expression of HOTAIR is up-regulated in blood samples of patients with CAD.


  • Open Access

    The effect of reducing the incidence of gastrointestinal complications in patients treated with aspirin, referred to Imam Hospital, of Ahvaz, Iran

    by Abdalrahim Masjedizade, Mohammad Javad Mohammadi, Saeed Yazdankhah, Atefeh Roumi, Arman Shahriari, Sahar Geravandi


  • Open Access

    Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography

    by Ahmadreza Assareh, Saeed Yazdankhah, Shahla Majidi, Nasim Nasehi, Seyed Seifollah Beladi Mousavi

    Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography


    • 3 April 2015
      • Vol. 10  (2) , 80-84
    Open Access

    Changes in Heart Rate Variability Parameters after Elective Percutaneous Coronary Intervention

    by Saeed Abrootan, Saeed Yazdankhah, Babak Payami, Mohammad Alasti

    Background: Patients with chronic stable angina often have a state of sympathetic hyperactivity. It is considered associated with myocardial ischemia and disappears after ischemia elimination. The aim of this study was to investigate the changes in heart rate variability parameters, a noninvasive technique for the evaluation of the autonomic nervous system activity, after successful revascularization in these patients to evaluate this theory.


  • Open Access

    Study of the Influence of Upper Extremities Variation on Transradial Success

    by Saeed Yazdankhah, Ahmadreza Assareh, Mehdi Easapour, Mohammad Nourizadeh, Farzad Daeenejad

    Background. To investigate whether the presence of arterial anomalies in upper limb arteries can influence the success rate of transradial coronary angiography. Methods. retrograde transarterial sheath injection was done in patients with transradial coronary angiography. Arterial anomalies in the upper limb are evaluated in these patients. There are ten brachial (5.4%), 7 radial (4/2%), 5 subclavian (3%), and 3 brachiocephalic arteries (1.8%). There also were 4 loops in ulnar artery (2.4%) and one in radial (0.6%). Except cannulation time (), there were associations between anomalies and other times () and contrast volume used (). Anomalies did not have any effect on procedural success rate and just in one patient because of subclavian loop,procedure changed to femoral approach (). Discussion. Patients without upper extremities anomalies in comparison with patients with anomalies had significantly shorter periods for angiographic time, catheterization time, and fluoroscopic time. We recommend femoral catheterization instead of radial catheterization in patients with upper extremities anomalies.


  • The Prevalence and Prognostic Role of Vitamin D Deficiency in Patients with Acute Coronary Syndrome: A Single Centre Study in South-West of Iran

    by Kamran Mahdavi, Zahra Amirajam, Saeed Yazdankhah, Shahla Majidi, Mohammad Hassan Adel, Bita Omidvar, Mohammad Alasti


    • 1 September 2012
      • Vol. 17  (9) , 859-864
    Open Access

    Defining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine level

    by Ahmadreza Assareh, Saeed Yazdankhah, Ahmad Ahmadzadeh, Mahdi Yadollahzadeh, Nasim Nasehi, Habib Haybar

    Background: Definitions of chronic kidney disease (CKD) in many catheterization laboratories have relied on the serum creatinine (Scr) rather than glomerular filtration rate (GFR). Regarding that CKD is the primary predisposing factor for contrast induced nephropathy (CIN), we compared the sensitivity of calculated GFR by 24-h Urine creatinine with Cockcroft-Gault (CG) equation and Scr level to define at risk patients for CIN who were undergone coronary angiography (CAG). Materials and Methods: Two hundred fifty four subjects who were candidate for CAG and had normal creatinine level were enrolled. Before CAG, GFR was calculated from a 24-h urine collection, CG equation and a single Scr sample regarding to previously described protocol. Contrast volume used for each case <100 ml. CIN was defined as a 0.5 mg/dL or 25% elevation in the Scr. Results: CIN occurred in 10.6%. Baseline GFR, the volume of contrast agent, and diabetes were the independent risk factors for CIN. GFR was less than 60 ml/min/1.73 m2 in 28% and 23.2% of patients regarding to 24-h urine creatinine and CG equation, respectively. In CIN prediction, 24-h urine creatinine estimated GFR had 85.2%, 59.3% and CG equation GFR had 78.9%, 81.1% sensitivity and specificity, respectively. Conclusion: Although, GFR estimated by CG equation has less sensitivity than GFR calculated from 24-h creatinine in CIN probability, but it is better than Scr alone and because of cost-effectiveness and convenience using of this method, we suggest at least using CG equation for GFR calculation before CIN, especially in diabetic and/or older than 60 years cases.